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 Introduction 
 Inclusion of live cells in additive manufacturing processes has 
seen tremendous progress in the last few years. Mammalian 
cells need to be kept in a soft, aqueous environment when 
embedded in a biomaterial matrix—this does not allow for the 
fabrication of structurally well-defi ned volumetric cell-laden 
constructs by means of three-dimensional (3D) bioprinting.  1 
Thus, creating macroscopic objects was found to be more 
complicated than initially expected. Simple upscaling is not 
possible due to the mismatch between the mechanical proper-
ties needed for cell embedding and manufacturing of 3D objects 
with high shape fi delity, hence several strategies have been 
investigated to overcome this problem. 
 Two main technologies can be distinguished—inkjet- and 
extrusion-based.  Figure 1 a shows schematic representations 
of both technologies and the respective terminology. For bio-
printing with inkjet-like printers, either single-cell suspensions 
(not suitable for manufacturing of volumetric structures), cell 
aggregates or cells encapsulated in hydrogel beads can be 
utilized as building blocks. This technology allows for achiev-
ing high cell densities, and hence it is advantageous for bio-
printing of artifi cial organs in which close cell–cell contacts 
are crucial for proper function. The disadvantage of utilizing 
cell aggregates as building blocks is the need to produce large 
numbers of cells and assemble them into spherical aggregates; 
both are cost-intensive and time-consuming procedures. 
For this type of cell-printing, the term “bioassembly” has been 
suggested to distinguish it from extrusion-based bioprinting.  2 
Norotte and co-workers used the bioassembly technology, 
for example, to create hollow, blood vessel-like morphologies 
by arranging spherical cell aggregates in 2009.  3 
 Utilizing extrusion-based bioprinting where cells (or small 
cell aggregates) are typically suspended in (bio)polymer 
hydrogels has made the manufacturing of volumetric structures 
easier and less expensive. Since the applicability of biomaterials 
in extrusion-based 3D printing is actually limited only by their 
viscosity, a wide range of materials can be utilized. In addi-
tion, 3D printers for this technology are already commercially 
available for less than USD$10,000, and construction kits are 
available for even less. Combinations of hydrogels and cells 
are called bioinks. As previously mentioned, after the extru-
sion process, bioinks must form soft hydrogels to support 
cell survival and maintenance over longer cultivation periods. 
In  Figure 1b , hydrogel formation from a cell-laden bioink is 
shown schematically. Low-viscosity materials are not suitable for 
the manufacturing of large, and still structurally well defi ned, 
constructs and novel strategies had to be developed to enable 
both—successful bioprinting and fabrication of volumetric 
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tissue-like objects. This article describes the most important 
and effective approaches to overcome this problem, and also 
the need to provide open macropores or perfusable channels 
in 3D tissue constructs to allow oxygen and nutrient supply to 
the embedded cells.
As 3D bioprinting moves from being a field of research 
toward real clinical applications, we define the term “vol-
umetric” in this article to only include technologies that, 
in principle, can be used for fabrication of cell-laden con-
structs with a volume of at least 1 cm3 (10 × 10 × 10 mm3). 
Although the studies selected for review in this article do 
not all describe macroscopic objects of this defined size, the 
selected technology should, in estimation, be able to fabri-
cate constructs with such dimensions. We have classified 
the selected studies based on the methodology and have 
distinguished between those utilizing special printing tech-
nologies, modified bioinks, or additional supporting mate-
rials. The last can be extruded with the bioinks either in an 
alternating fashion (separate bioink and support strands) or 
in a combined manner, leading to strands with core–shell 
morphology. These approaches are listed in Table I,4–7 with 
a schematic and an example taken from literature, respec-
tively. Other articles in this issue describe in detail new 
research directions in bioink development (see the Rutz 
et al. article in this issue)8 as well as questions of perfusion/ 
vascularization of bioprinted tissue constructs (see the Huang 
et al. article in this issue).9
It is worth mentioning that the morphology of mammalian 
tissues and organs is quite diverse and different solutions have 
to be developed to mimic those as closely as possible, in terms 
not only of structural aspects, but also with regard to the com-
position of the respective extracellular matrices.10 Different 
technologies must be used to print, for example, nonvascu-
larized but mechanically stable articular cartilage constructs 
containing only one cell type (chondrocytes, [i.e., cartilage 
cells]) in contrast to highly vascularized, multiple cell types 
containing organs such as the liver or kidney.
Finally, we point out that the first studies on 3D bioprinting of 
nonmammalian cells have been published, which might open 
up new applications (e.g., in the field of biotechnology).11 
For these, diverging novel methods and materials will require 
further development.
Technical solutions
Specific printing environment
In order to overcome the limitations of common 3D bioprint-
ing setups concerning structural stability, choice of material, 
dispensing systems, and concepts, modifying the procedural 
setup are essential. Different innovative approaches have been 
established to prevent the structure from deliquescing by pro-
viding a supportive inert solvent-based (e.g., dispensing into 
fluorocarbon) or additional particle-based printing environment 
(e.g., gelatin microparticle bath), or by in situ-compatible 
cross-linking mechanisms.
Although most currently used setups enable dispensing into 
air and onto a firm surface, a proposed solution is to use spe-
cific dispensing environments to enable immediate temporary 
stabilization of extruded strands, thus preventing deliques-
cence. The selected dispensing medium stabilizes the printed 
structure, maintaining its shape while being extruded. The 
surrounding medium should not mix with the dispensed 
material, affect or degrade the material in a destabilizing 
way, nor interfere with the cytocompatibility. For example, 
for highly hydrophilic hydrogels such as agarose, hydrophobic 
and completely inert fluorocarbons have been used,12 enabling 
the manufacturing of a variety of differently shaped constructs 
and mediating scaffold stability over several months.
Another option is to utilize an additional hydrogel bath with 
gelatin microparticles acting as a sacrificial Bingham fluid, 
which shows viscous behavior at higher shear stress, and enables 
stabilization of the extruded structure.13 This idea is referred to 
as freeform reversible embedding of suspended hydrogels as 
the dispensed, cell-loaded alginate (alginic acid salts frequently 
used as biopolymer-hydrogels in biological application) 
hydrogel is simultaneously cross-linked ionically by CaCl2 
added to the gelatin gel. After printing and stabilization, the 
gelatin is melted by increasing the temperature to 37°C and 
finally removed from the bioprinted structure.
For thermoresponsive materials such as gelatin and gela-
tin blends, their thermosensitivity is used to induce gelation 
and initial stability via temperature-controlled printer hard-
ware. Zhang et al. reported alginate-gelatin gels that gelled at 
Figure 1. Principles of (a) (left) extrusion- and (right) inkjet-based 
3D printing enabling manufacturing of volumetric constructs. 
(b) Hydrogel formation after ionic or covalent cross-linking 
of the bioink (cell suspension in less viscous (bio)polymer 
solution), essential for stabilization of volumetric bioprinted 
structures.
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Table I. Principles of fabricating volumetric tissue constructs by extrusion bioprinting approaches and respective examples.  
The cell-laden bioink strands are shown in red in the schematics.
Category Principle Example
1
Technical  
solutions
Technical procedure for scaffold stabilization (e.g., CaCl2  
aerosol spray enabling cross-linking in situ)
Three-dimensional printed alginate structure, fabricated via continuous platform- 
lowering into stabilizing cross-linking solution, resembling a vascular tube  
(tube diameter 10 mm, height ca. 35 mm).4
2
Internal  
stabilization
Internal stabilization of hydrogel (red) strands by  
blending with additional polymer material(s) (black)
Nanofibrillated cellulose-alginate bioink (80:20) printed in the shape of a human ear with  
high shape fidelity (dimensions ca. 20 × 25 × 10 mm3). This blend offered excellent  
properties for printing of chondrocytes.5
3
External  
stabilization
External structure stabilization of cell-laden hydrogel  
(red) by a second, stiffer biomaterial (gray)
Three-dimensional printing of an ear with a PCL frame. The auricular cartilage region is  
colored red, and the lobe fat tissue is blue (dimensions ca. 20 × 25 × 8 mm3).6
4
Core–shell  
morphology
Modification of strand morphology by core–shell  
(core: red; shell: gray) setup based on two  
different (cell-laden) materials Three-dimensional printed core–shell scaffold with fluorescently labeled cells (green) in  
the core surrounded by the shell (gray). The inset illustrates the core–shell morphology  
of such scaffolds in bright-field microscopy. Stability to the construct was provided by  
cross-linking the shell components by ionic cross-linking and photocuring. Printing of a 
cube with 20 × 20 × 20 mm3 without cells was demonstrated.7
Note: PCL, poly(ε-caprolactone).
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3–10°C directly after deposition of the strands, the continu-
ously extruded hydrogel filaments used to build the scaffold 
layers.14 Another study described utilization of an alginate-
gelatin blend, including hydroxyapatite supplementation15 
gelling on a 10°C cooling plate after being dispensed from 
a 40°C temperature-controlled cartridge system. Printers 
equipped with cooling plates or chambers can also be applied 
to induce in situ solidification of non-thermoresponsive mate-
rials such as alginate on a stage at –10°C.16 In most cases, the 
proposed procedures require an additional cross-linking step 
for providing long-term stability of the constructs. New ways 
are opening up by combining techniques for specific materials, 
such as two-step gelation (thermic/ionic) after dispensing an 
alginate-gelatin hydrogel into a granular carbopol (polyacrylic 
acid particles) support bath.17
In situ cross-linking approaches
To fabricate volumetric tissue constructs, another aspect of 
stability optimization during the printing process that should 
be considered is the cross-linking procedure. Ideally, the 
bioink needs to be cross-linked directly following dispension 
from the nozzle, which remains a challenge, particularly for 
air-dispensing setups. To enable immediate contact between the 
printed ink and a cross-linking reagent that induces gelation, 
one approach applies a continuous spray of a CaCl2 aerosol18 
on open-porous alginate-based scaffolds.
Tabriz and co-workers described utilization of an alginate 
gel, precross-linked with a low concentration of calcium ions 
prior to extrusion and being further ionically cross-linked by 
lowering the building platform along the z-axis into a CaCl2 
bath during the biofabrication process.4
Many concepts utilize UV-/photocross-linkable hydrogels 
for bioprinting as they allow for defined and reproducible con-
trol of spatiotemporal polymerization. Photoreactive chemical 
groups are incorporated in the materials to enable covalent 
cross-linking in response to UV illumination.19 However, the 
most critical aspect of UV-cross-linked cell-laden scaffolds 
is the impact of the illumination on DNA structures, by both 
the UV light and the radicals (radicals generated by UV 
interaction with the respective-photo initiators) accounting 
for both UV-A and UV-B wavelength ranges. UV-A is gen-
erally considered less disruptive than the shorter wavelength 
UV-B. With Irgacure 2959 investigated as the photoinitiator, 
the expected adverse effects of photopolymerization on DNA 
integrity and cell cycle reentry (i.e., ability of cells to pro-
liferate) of human mesenchymal stem cells (hMSCs) were 
confirmed as being stronger for monolayer cultures compared 
to hMSCs embedded in hydrogels.20
Early approaches to translate the photocross-linking 
of hydrogel blends that had been applied for years to a 
bioprinting-compatible setup were performed using the non-
ionic triblock copolymer (poloxamer) Lutrol-F127, enabling 
both thermogelation and covalent photocross-linking.21 Later, 
those concepts were used for simultaneous cross-linking 
of synthetic hydrogels while being dispensed, such as for 
poly(ethylene glycol) dimethacrylate gels for cartilage tissue 
engineering. In this case, increased cell viability was obtained 
for in situ cross-linking outperforming previous post-printing 
approaches.22 However, when considering translational 
approaches for clinical applications, the risk of DNA damage 
needs to be assessed.
One approach to at least reduce DNA interruption is 
employing ultrafast methods, where the cross-linking time 
could be reduced. Wang and co-workers recently investi-
gated possible strategies in this direction but did not produce 
volumetric bioprinted structures.23 Another current study sug-
gested in situ cross-linking via photopermeable dispensing 
nozzles, generalizable for different bioinks such as gelatin 
methacryloyl (GelMA) and polyethylene glycol diacrylate 
(PEGDA),24 and wavelengths in the UV and visible light range. 
This enables simultaneous cross-linking and extrusion without 
affecting viscosity (i.e., viscosity does not decrease by poten-
tial UV-induced molecular chain break and does not increase 
due to unspecific cross-linking), even along with core–shell 
structured extrusion.
Internal structure stabilization (modified bioinks)
The simplest technique to build up volumetric structures 
by additive manufacturing is to increase the viscosity of the 
hydrogel bioink. A printed construct consisting of a high-
viscosity bioink will not collapse before further processing, 
for example, cross-linking. Generally, high-viscosity bio-
inks allow fabrication of scaffolds with high shape fidelity. 
However, tailoring the viscosity is a critical issue, as just 
a plain increase in the polymer concentration leads to stiff 
hydrogels unsuitable for cell encapsulation.1 Overall, the 
criteria for development of bioinks with high viscosity are 
ambitious and diverse.25
Two main strategies have been investigated to enhance the 
shape fidelity and stability of cell-laden constructs—modifying 
the bioink composition or modifying single components of 
the ink to increase their cross-linking density. The effects 
of adding a second material to the original bioink on the prop-
erties of the resulting blend can be numerous. Changes in the 
rheological properties are consequential, and shear thinning 
behavior or printing fidelity are affected strongly by blend 
composition.
Markstedt et al. infiltrated an alginate sol with nanofibril-
lated cellulose (NFC) in a 80:20 ratio (Table I, Category 2).5 
They observed shear thinning behavior, necessary for 3D 
printing, and a viscosity, which enabled the scaffold to main-
tain its shape during the printing process until cross-linking of 
the alginate component occurs. The insoluble NFC remained 
inside the hydrogel matrix.
In contrast, further studies show that the viscosity can also 
be enhanced temporarily by incorporation of materials that 
vanish from the matrix after printing. These materials are not 
fixed but stay soluble and diffuse into the cell culture medium, 
leaving behind a cross-linked low polymer content hydrogel 
that is especially qualified for cell incorporation. Schütz et al. 
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mixed 9 wt% methylcellulose in a cell-laden 3 wt% alginate 
bioink.26 After dispensing, carried out in air, the alginate was 
cross-linked ionically with calcium ions, while the soluble 
methylcellulose was shown to diffuse out of the scaffold. 
Printed scaffolds showed high shape fidelity, and the blend 
could be printed with a large (>50) number of layers. After 
methylcellulose vanished from the scaffold, the cross-linked 
alginate maintained its shape and presented a low concentra-
tion polymer matrix, consisting of only the alginate part, to 
the cells.
Even macroporous, cell-laden constructs could be fabri-
cated with this bioink blend. It was demonstrated that hMSCs 
could be differentiated toward adipogenic lineage (fat tissue) 
after printing. A similar approach was investigated by blend-
ing 6% alginate with 13% of the triblock-copolymer polox-
amer Pluronic F127.27 The blend was printed at 37°C, which 
is the solidifying temperature of the Pluronic F127. The scaffold 
fabricated from this bioink remained stable at physiologi-
cal temperature. After printing, the alginate component was 
cross-linked by calcium ions at room temperature, and the 
destabilized Pluronic vanished from the scaffold. Similar 
results were obtained for gelatin in alginate–gelatin blends, in 
which utilization for bioprinting is discussed in the “Technical 
solutions” section.14,15 Both methylcellulose and Pluronic left 
behind a distinct intrastrand micropore structure that could 
be advantageous for the oxygen and nutrient supply of the 
embedded cells during further cultivation or implantation.
The other strategy focuses on chemical modification 
of the bioink components to enable faster cross-linking or 
higher cross-linking density, which is important for accu-
rate bioprinting.19 We provide a brief overview of the three 
precross-linking techniques that enhance the printing behav-
ior of cell-laden hydrogels.
Photopolymerization enhances the stability of printed 
structures.28 For example, gelatin Type B can be reacted with 
methacrylic anhydride to obtain GelMA, which is the most 
commonly applied photosensitive hydrogel in bioprinting 
applications. Billiet et al. demonstrated that its dual cross-
linking capabilities, physical cross-linking by cooling down 
immediately after printing and photoinitiated cross-linking 
shortly after printing, allowed perfect scaffold construc-
tion from 10–20% weight/volume GelMA pastes.29 Building 
large constructs with high printing fidelity and a connected 
internal pore network was possible. Cell encapsulation of the 
hepatocarcinoma (liver cancer) cell line and printing of the 
cell-laden hydrogel revealed a cell viability of more than 
97%, obtained immediately after printing as well as after 
cultivation for 14 days.29
Rutz and co-workers synthesized gel-phase bioinks by slight 
cross-linking of gelatin and fibrinogen solutions prior to 
printing (precross-linking) with poly(ethylene glycol) (PEG) 
ending in two reactive groups, called PEGX (PEG with X as 
placeholder for the reactive groups).30 The precross-linking 
enhanced the printing properties; for long-term cell culture, 
an additional post-printing cross-linking step was applied to 
ensure full cross-linking of the hydrogel. Kesti et al. created 
a blend by ionic precross-linking with a low concentration of 
divalent metal ions that was shown to be beneficial for extru-
sion of an alginate (2%)–gellan gum (3%) blend. Such presta-
bilized structures of this blend were robust during the printing 
process and further strengthened by a supply of more divalent 
cations, which cross-link alginate and gellan gum, from a 
co-extruded support structure.31
The cell vitality of all approaches ranges between 50 and 
90%, however, the number of living cells was demonstrated 
to be dependent on the cell position inside a 3D construct 
with a greater number of living cells near the periphery, likely 
due to limitations of oxygen supply and duration of keeping 
the cells under nonphysiological conditions.31
External stabilization (bioink plus support)
Hydrogels with high polymer content cannot be used for cell 
encapsulation due to their limited water content, which is most 
important for the cell environment. Multichannel (multimate-
rial) printing is a method to combine both a tough and robust, 
grid-like structure as a mechanical support with a soft, cell-
containing hydrogel. For this, at least two materials are loaded 
in separate cartridges. First, cell-free, viscous materials are 
printed as a grid. After finishing the grid of the first layer, the 
less viscous, cell-laden hydrogel is printed inside the voids of 
the grid. Schuurman et al. first demonstrated this concept in 
201132 by printing thermoplastic poly(ε-caprolactone) (PCL) 
as the rigid grid next to a cell-containing alginate hydrogel; 
this was repeated by other groups for several bioprinting 
applications.33,34 With additional usage of PEG as the sacrifi-
cial material, PCL as the grid structure, and an alginate bioink, 
this technique allowed for the construction of real 3D printed 
tissues, such as cartilage in the shape of a human ear (Table I, 
Category 3).6
As soft bioinks fill up the pores of the grid, large volumetric 
constructs generated by these methods might lead to prob-
lems, because the oxygen supply is limited for cells inside the 
scaffold. Moreover, in the case of an intended implantation, an 
open-porous structure would be needed for vascularization 
(i.e., ingrowth of blood capillaries from the surrounding tissue).
Kolesky et al.35 demonstrated an advanced concept to 
directly achieve volumetric tissue structures with perfusable, 
vessel-like pore channels by combining 3D printing, bioprint-
ing, and conventional cell-seeding techniques. The 3D pore 
channel system was fabricated from Pluronic F-127 as the 
sacrificial material and subsequently internally endothelialized 
(formation of the blood vessel lining by endothelial cells) 
with human umbilical vein endothelial cells, which consti-
tutes the overall concept of inducing vascularization in thick 
constructs. Perfusion of this microcapillary network allowed 
survival of embedded cells in macroscopic constructs of ca. 
25 × 25 × 10 mm3 volume during a six-week time period.
Kim and co-workers developed scaffolds with open 
pores by extruding a cell-containing and precross-linked 3% 
alginate-based bioink directly on top of printed PCL strands.36 
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The bioink surrounded the PCL strands and the hydrogel did 
not clog the macropore structure of the PCL grid, which 
remained open even after swelling of the hydrogel. Lee et al. 
printed PCL strands next to an internally stabilized cell-laden 
alginate, which was precross-linked by calcium ions.37 The 
open macropore structure of this approach can be adjusted 
by changing the layer orientations or the strand-to-strand 
distance. Cells seemed to tolerate the direct contact to the hot 
PCL melt, because they were protected by the surrounding 
hydrogel.
Melchels et al. took an alternative approach and engi-
neered a synthetic poloxamer (Pluronic F127) hydrogel with 
high viscosity and good printing fidelity that was printed at 
room temperature together with a cell containing GelMA bio-
ink, kept at 37°C, and achieved cell viabilities greater than 
80% after printing and greater than 90% after 14 days in cell 
culture.38
For bone applications, calcium phosphate mineral phases 
are suitable materials, due to their high biocompatibility, bone-
like composition, and mechanical strength. Pasty, extrudable 
calcium phosphate cements (CPCs) that can set to biodegrad-
able, nanocrystalline hydroxyapatite are well suited for 3D 
printing.39 Lode et al. printed this CPC together with an inter-
nally stabilized, hMSC-laden alginate-methylcellulose blend 
bioink, mentioned previously, thereby achieving open pores 
in vertical and lateral directions and volumetric constructs that 
could be printed with high accuracy (Figure 2). Over time, 
hMSCs migrated from the bioink to the CPC at the interface 
region of the two materials, and attached to the CPC surface 
and started to proliferate there.40
Modification of strand morphology (core–shell 
bioprinting)
For retaining the viability of cells during bioprinting, low 
concentrated bioinks are generally preferred. However, for 
printing volumetric tissue constructs, low concentrated (less 
viscous) bioinks need to be extensively modified, or alternative 
strategies (previously mentioned) need to be employed to sta-
bilize the construct, at least intermediately, until the printing 
process is completed and the bioink gels or is cross-linked. 
A relatively simple yet efficient strategy would be rendering 
intrastrand stability during the extrusion/printing process.
Encapsulating a low concentrated bioink with a highly con-
centrated (highly viscous) biomaterial within a single strand 
(i.e., forming a core–shell strand) would support printing of 
subsequent layers without extensively altering the shape and 
size of the whole construct (see Table I, Category 4). As two 
materials (spatially separated) are extruded as a single strand 
using coaxial nozzles, additive effects of their intrinsic prop-
erties are observed.41 Also, independent functions of the two 
materials can be simultaneously utilized, for example, as a 
dual drug delivery system by selectively loading the core and 
the shell with different drugs or growth factors.42
The properties of the constructs, such as mechanical strength 
and release kinetics, can be easily tuned for specific biomedi-
cal applications by altering the composition of core or shell 
materials. Onoe et al. demonstrated this by using a microflu-
idic system for inclusion of various cells in the core (consist-
ing of natural extracellular matrix proteins) encapsulated by 
Ca–alginate shell that resulted in high order organization of 
the cells and formation of respective meter-long functional 
tissue fibers.43 However, such long cell fibers would still need 
to be organized in three dimensions to form a volumetric 
tissue construct.
Alternatively, extrusion-based bioprinting of cell-laden core–
shell structures can be used for fabrication of volumetric 
tissues. Cells can be loaded in either the core42,44 or the shell 
material45,46 to fabricate cell-laden volumetric tissue con-
structs. If cells are located in the shell region, the stabilizing 
core can consist of either a stiff biopolymeric material45 or a 
self-setting calcium phosphate suspension.46 Other materials 
for this purpose will most likely be established in future.
Different cell types encapsulated in the core successfully 
reorganized to form functional tissue strands (e.g., formation 
of tubular structures from endothelial cells, 
functional cardiomyocytes [cardiac muscle 
cells], and conducting cortical neural cells43) 
or were differentiated into a specific lineage 
(e.g., differentiation of human adipose [body 
fat]-derived stem cells to cells showing high 
levels of liver-specific gene expression44). 
Constructs having two different cell types 
spatially separated in a single strand can poten-
tially be fabricated using core–shell extrusion 
printing. The two cell types can independently 
reorganize to form a functional tissue or aid 
in interacting with each other, leading to the 
formation of complex tissues.
Combination of several categories
Advancements in bioinks and 3D printing 
technologies have led to easier and more 
Figure 2. Example of external stabilization. A volumetric bone tissue construct, 
fabricated with a self-setting, pasty calcium phosphate cement (CPC). (a) Schematic, 
showing the scaffold design (white = CPC strands, red = cell-laden hydrogel strands); 
(b) micrograph after MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 
staining for metabolic activity of encapsulated cells, one day after printing dark violet 
dots represent vital cells, embedded in the hydrogel strands, CPC strands are white. 
(c) Fluorescence micrograph, taken 21 days after printing; live/dead staining: live 
cells (>90%) show green, dead cells show red fluorescence; CPC strands exhibit green 
autofluorescence.40 Scale bars in (b–c) = 3 mm; the whole scaffold is 10 × 10 × 5 mm3.
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efficient bioprinting of volumetric tissue constructs by 
employing more than one strategy. hMSC-laden 3D scaf-
folds with high resolution (strand diameter of ∼150 µm) were 
printed for cartilage tissue-engineering applications.47 Low 
concentrated bioink solutions (consisting of photocurable 
bioinks + alginate) with a high concentration of hMSC 
suspension were used for printing. Instantaneous gelation of 
alginate (by simultaneous extrusion of CaCl2 using a coaxial 
needle) led to printing of stable 50-layered constructs. Further 
stabilization of the construct was achieved by UV cross-
linking of the respective components in the bioinks. Jia et al. 
fabricated perfusable vascular constructs48 by coaxial printing 
of photocurable bioinks and alginate blends with CaCl2 solu-
tions. Mistry and co-workers have simultaneously employed 
strategies mentioned earlier in the “technical solutions” and 
“internal structure stabilization” sections for printing cell-
laden volumetric constructs.7
Conclusions
Various approaches concerning bioprinting of volumetric tissue 
constructs have been proposed, and the field is still developing 
quickly. By carefully considering all aspects—the extrusion 
process, bioink composition, and cytocompatible gelation 
protocols—suitable strategies for different types of tissues 
and organs can be employed. We still have a long way to 
go until macroscopic, mechanically robust tissue equivalents 
can be fabricated by 3D bioprinting technologies to be used 
in human therapies.
One limitation is that most of the studies published so far 
have utilized immortalized, cancer-derived human or mam-
malian cell lines that are known to be more resistant to stress, 
which may occur during bioprinting or gelation, as compared 
to primary cells. As immortalized cell lines (cells in a cul-
ture that are genetically modified for indefinite proliferation) 
cannot be applied in clinical settings, more research needs to 
be performed on bioprinting using patient-derived, primary 
cells. Certainly, new biomaterials and material combinations, 
as well as novel technological solutions, will be introduced to 
the field, and we will surely see continued strong progress. 
An open question today remains whether mankind will be 
able to fabricate fully functional, complex tissue equivalents 
by means of 3D bioprinting. The question of how to fabricate 
volumetric 3D constructs will be one of the key challenges.
This article is dedicated to Professor Wolfgang Pompe on the occasion 
of his 75th birthday.
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